REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 204 filers reported holding REATA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 2.50 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $384,899 | -33.0% | 3,775 | -40.3% | 0.01% | -26.3% |
| Q1 2023 | $574,614 | +62.7% | 6,320 | -32.0% | 0.02% | +46.2% |
| Q4 2022 | $353,117 | +49.6% | 9,295 | -1.0% | 0.01% | +44.4% |
| Q3 2022 | $236,000 | -24.6% | 9,387 | -9.0% | 0.01% | -18.2% |
| Q2 2022 | $313,000 | -52.4% | 10,315 | +57.6% | 0.01% | -45.0% |
| Q3 2021 | $658,000 | -26.9% | 6,544 | +2.9% | 0.02% | -25.9% |
| Q2 2021 | $900,000 | +107.9% | 6,360 | +46.4% | 0.03% | +92.9% |
| Q1 2021 | $433,000 | -5.7% | 4,345 | +17.0% | 0.01% | -12.5% |
| Q4 2020 | $459,000 | – | 3,715 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |